Sidley Honored for Four “Deals of the Year” 2023 by China Business Law Journal

Four Sidley matters have been recognized as “Deals of the Year” 2023 by the China Business Law Journal (CBLJ). Each year, CBLJ recognizes the “most significant China-related deals and cases” of the past 12 months as the “Deals of the Year.”

CBLJ has identified the following Sidley matters as “Deals of the Year”:

• Akeso, Summit Therapeutics collab and licensing over ivonescimab
• Bitdeer’s Nasdaq listing via de-SPAC
• I-Mab, Tracon dispute over dual collaboration agreements
  
• Lepu, Keymed exclusive licence of CMG901 to AstraZeneca